Evidence map›Paper›PMID 34314419›Full record

ArticlePLoS genetics2021

Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells.

Brady G Strittmatter, Travis J Jerde, Peter C Hollenhorst

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Expression of Proto-OncogeneInternational journal of molecular sciences · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Brady G StrittmatterDepartment of Molecular and Cellular Biochemistry, Indiana University, Bloomington, Indiana, United States of America.ORCID 0000-0001-6989-0038
Travis J JerdeDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.ORCID 0000-0002-1160-4665
Peter C HollenhorstMedical Sciences, Indiana University School of Medicine, Bloomington, Indiana, United States of America.ORCID 0000-0002-1995-0028
Indiana University Bloomington · USIndiana University School of Medicine

Funding

Graduate Training Program in Quantitative and Chemical Biology at Indiana University BloomingtonT32GM131994 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI JARED C LEWIS · 2019 to 2026
$2.4M
Interleukin-1 and Steroid Signaling Drive Toxoplasma-induced Prostatic HyperplasiaR01DK124067 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI ARRIZABALAGA, GUSTAVO A, JERDE, TRAVIS J · 2020 to 2023
$2.1M
Molecular mechanisms specific to ETS transcription factors that drive oncogenesisR01CA204121 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI HOLLENHORST, PETER CELESTINE · 2017 to 2021
$1.8M
Graduate Program in Quantitative and Chemical Biology at Indiana University BloomT32GM109825 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI GIEDROC, DAVID P. · 2014 to 2018
$926k
NCI NIH HHS R01 CA204121NIDDK NIH HHS R01 DK124067NIGMS NIH HHS T32 GM109825NIGMS NIH HHS T32 GM131994
6 · The paper itself

Abstract

The TMPRSS2/ERG gene rearrangement occurs in 50% of prostate tumors and results in expression of the transcription factor ERG, which is normally silent in prostate cells. ERG expression promotes prostate tumor formation and luminal epithelial cell fates when combined with PI3K/AKT pathway activation, however the mechanism of synergy is not known. In contrast to luminal fates, expression of ERG alone in immortalized normal prostate epithelial cells promotes cell migration and epithelial to mesenchymal transition (EMT). Migration requires ERG serine 96 phosphorylation via endogenous Ras/ERK signaling. We found that a phosphomimetic mutant, S96E ERG, drove tumor formation and clonogenic survival without activated AKT. S96 was only phosphorylated on nuclear ERG, and differential recruitment of ERK to a subset of ERG-bound chromatin associated with ERG-activated, but not ERG-repressed genes. S96E did not alter ERG genomic binding, but caused a loss of ERG-mediated repression, EZH2 binding and H3K27 methylation. In contrast, AKT activation altered the ERG cistrome and promoted expression of luminal cell fate genes. These data suggest that, depending on AKT status, ERG can promote either luminal or EMT transcription programs, but ERG can promote tumorigenesis independent of these cell fates and tumorigenesis requires only the transcriptional activation function.

Indexed as

AnimalsCarcinogenesisCell Line, TumorCell MovementCell Transformation, NeoplasticEpithelial-Mesenchymal TransitionExtracellular Signal-Regulated MAP KinasesGene ExpressionGene Expression Regulation, NeoplasticGenes, RegulatorHeterograftsHumansMaleMAP Kinase Signaling SystemMiceMice, NudeERG protein, humanExtracellular Signal-Regulated MAP KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktras ProteinsTranscriptional Regulator ERGTranscription Factors

Identifiers

PMID34314419
PMCPMC8345871
OpenAlexW3184425470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.